Aziz T, Burgess M, Rahman A, Campbell C, Deiraniya A, Yonan N
Cardiac Transplant Unit, Wythenshawe Hospital, Southmoor Road, Manchester, UK.
Eur J Cardiothorac Surg. 2000 Apr;17(4):349-54. doi: 10.1016/s1010-7940(00)00365-1.
The aim of this study was to evaluate the preoperative management and long-term survival of patients undergoing heart transplantation as a redo-operation and compare the results with those obtained in patients undergoing transplantation as their first cardiac surgical procedure.
Between 1990 and 1997, 49 heart transplantation procedures were performed in patients who had undergone previous cardiac surgery (group A). This subgroup of patients was compared to 109 control patients who underwent cardiac transplantation as the primary cardiac procedure (group B). Patient groups were analysed regarding their preoperative, intra-operative, and postoperative variables in addition to survival.
Pre-operative events were comparable in both groups but the duration of the operation was longer for group A (311+/-68 min) compared to group B (202+/-34 min); P=0.02. Post-operative exploration for bleeding was 6/49 patients in group A compared to 2/107 patients in group B (P=0.02). Post-operative blood loss and intensive care stay were greater for group A (1302+/-360 ml and 6.1+/-3.1 days, respectively) compared to group B (763+/-126 ml and 4.1+/-1.9 days, respectively); P=0.02. There was no difference in hospital mortality (group A 12.5%, group B 13 % P=0.9) and the 5-year survival rates were 68 and 71% for group A and B, respectively (P=0.9).
Heart transplantation after previous open cardiac surgery is entirely justified in terms of outcome and graft function even in time of profound organ scarcity. Long-term events in these recipients are similar to patients in whom transplantation is the primary procedure.
本研究旨在评估再次心脏移植患者的术前管理和长期生存情况,并将结果与首次接受心脏手术的移植患者进行比较。
1990年至1997年间,对49例曾接受过心脏手术的患者进行了心脏移植手术(A组)。将该亚组患者与109例作为初次心脏手术接受心脏移植的对照患者(B组)进行比较。除生存情况外,还对患者组的术前、术中和术后变量进行了分析。
两组术前情况相当,但A组手术时间(311±68分钟)比B组(202±34分钟)长;P = 0.02。A组术后因出血进行探查的患者为6/49例,而B组为2/107例(P = 0.02)。A组术后失血量和重症监护停留时间比B组更长(分别为1302±360毫升和6.1±3.1天,而B组分别为763±126毫升和4.1±1.9天);P = 0.02。两组医院死亡率无差异(A组12.5%,B组13%,P = 0.9),A组和B组的5年生存率分别为68%和71%(P = 0.9)。
即使在器官严重短缺的情况下,既往心脏直视手术后进行心脏移植在预后和移植物功能方面也是完全合理的。这些受者的长期情况与初次进行移植手术的患者相似。